Yield10 Bioscience Announces Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Yield10 Bioscience, Inc. (YTEN) Tops Q3 EPS by 7c
November 12, 2020 4:39 PM ESTYield10 Bioscience, Inc. (NASDAQ: YTEN) reported Q3 EPS of ($0.87), $0.07 better than the analyst estimate of ($0.94). Revenue for the quarter came in at $204 thousand versus the consensus estimate of $240 thousand.
"We are very pleased with our strong progress across multiple fronts in the third quarter and beyond," said Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10 Bioscience. We completed harvesting for our 2020 field test program to evaluate novel yield and compositional traits in Camelina and... More
